295 related articles for article (PubMed ID: 35425980)
1. Anti-neutrophil cytoplasmic antibody-associated vasculitis complicated by thrombotic microangiopathy with posterior reversible encephalopathy syndrome successfully treated with eculizumab: A case report.
Kitamura F; Yamaguchi M; Nishimura M; Katsuno T; Ito M; Sugiyama H; Iwagaitsu S; Nobata H; Kinashi H; Ishimoto T; Banno S; Ito Y
Mod Rheumatol Case Rep; 2022 Jun; 6(2):254-259. PubMed ID: 35425980
[TBL] [Abstract][Full Text] [Related]
2. [Case Report: Atypical posterior reversible encephalopathy syndrome (PRES) and thrombotic microangiopathy (TMA) in a hemodialysis patient with ANCA-associated vasculitis: a case report].
Sakai R; Sakurai S; Okada T; Takahashi T; Hayakawa S; Koji H; Iwasaki M; Iwamoto K
Nihon Naika Gakkai Zasshi; 2016 Feb; 105(2):275-9. PubMed ID: 27228724
[No Abstract] [Full Text] [Related]
3. Investigation of Clinical Features and Association between Vascular Endothelial Injury Markers and Cytomegalovirus Infection Associated with Thrombotic Microangiopathy in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis: Case-Based Research.
Nimura T; Aomura D; Harada M; Yamaguchi A; Yamaka K; Nakajima T; Tanaka N; Ehara T; Hashimoto K; Kamijo Y
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255886
[TBL] [Abstract][Full Text] [Related]
4. Postpartum thrombotic microangiopathy revealed as atypical hemolytic uremic syndrome successfully treated with eculizumab: a case report.
Kourouklaris A; Ioannou K; Athanasiou I; Panagidou A; Demetriou K; Zavros M
J Med Case Rep; 2014 Sep; 8():307. PubMed ID: 25219386
[TBL] [Abstract][Full Text] [Related]
5. Two cases of kidney transplantation-associated thrombotic microangiopathy successfully treated with eculizumab.
Ikeda T; Okumi M; Unagami K; Kanzawa T; Sawada A; Kawanishi K; Omoto K; Ishida H; Tanabe K
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():35-40. PubMed ID: 26970541
[TBL] [Abstract][Full Text] [Related]
6. Anti-neutrophil cytoplasmic antibody-associated vasculitis accompanied by type II heparin-induced thrombocytopenia resulting in asymptomatic cerebral infarction: a case report.
Furuto Y; Kawamura M; Yamashita J; Yoshikawa T; Namikawa A; Isshiki R; Takahashi H; Shibuya Y
BMC Nephrol; 2021 Jun; 22(1):220. PubMed ID: 34126959
[TBL] [Abstract][Full Text] [Related]
7. Complement-mediated thrombotic microangiopathy secondary to sepsis-induced disseminated intravascular coagulation successfully treated with eculizumab: A case report.
Abe T; Sasaki A; Ueda T; Miyakawa Y; Ochiai H
Medicine (Baltimore); 2017 Feb; 96(6):e6056. PubMed ID: 28178155
[TBL] [Abstract][Full Text] [Related]
8. The use of eculizumab in Capnocytophaga canimorsus associated thrombotic microangiopathy: a case report.
Bjørkto MH; Barratt-Due A; Nordøy I; Dörje C; Galteland E; Lind A; Hilli A; Aukrust P; Mjøen G
BMC Infect Dis; 2021 Feb; 21(1):137. PubMed ID: 33526010
[TBL] [Abstract][Full Text] [Related]
9. Isolated thrombotic microangiopathy of the small intestine in a patient with atypical hemolytic uremic syndrome - a case report.
Nunius C; Büttner-Herold M; Bertz S; Schiffer M; Buchholz B
BMC Nephrol; 2020 Mar; 21(1):104. PubMed ID: 32204691
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment with eculizumab for posterior reversible encephalopathy syndrome due to underlying transplant-associated thrombotic microangiopathy in patients transplanted for sickle cell disease.
Bhunia N; Abu-Arja R; Bajwa RPS; Auletta JJ; Rangarajan HG
Pediatr Blood Cancer; 2019 Oct; 66(10):e27912. PubMed ID: 31264793
[TBL] [Abstract][Full Text] [Related]
11. IgA vasculitis complicated by acute kidney failure with thrombotic microangiopathy: successful use of eculizumab.
Patel DM; Cantley L; Moeckel G; Dahl NK; Luciano R
J Nephrol; 2021 Dec; 34(6):2141-2145. PubMed ID: 34019254
[No Abstract] [Full Text] [Related]
12. A Case Report of Quinine-Induced Thrombotic Microangiopathy Successfully Treated With Eculizumab.
Ng JY; Lenton D; Kerridge I; Wong C
J Investig Med High Impact Case Rep; 2024; 12():23247096241235617. PubMed ID: 38477293
[TBL] [Abstract][Full Text] [Related]
13. A systematic review of the role of eculizumab in systemic lupus erythematosus-associated thrombotic microangiopathy.
Wright RD; Bannerman F; Beresford MW; Oni L
BMC Nephrol; 2020 Jun; 21(1):245. PubMed ID: 32605540
[TBL] [Abstract][Full Text] [Related]
14. Complete remission of thrombotic microangiopathy after treatment with eculizumab in a patient with non-Shiga toxin-associated bacterial enteritis: A case report.
Omura T; Watanabe E; Otsuka Y; Yoshida Y; Kato H; Nangaku M; Miyata T; Oda S
Medicine (Baltimore); 2016 Jul; 95(27):e4104. PubMed ID: 27399110
[TBL] [Abstract][Full Text] [Related]
15. Association of Serum C3 Concentration and Histologic Signs of Thrombotic Microangiopathy with Outcomes among Patients with ANCA-Associated Renal Vasculitis.
Manenti L; Vaglio A; Gnappi E; Maggiore U; Allegri L; Allinovi M; Urban ML; Delsante M; Galetti M; Nicastro M; Pilato FP; Buzio C
Clin J Am Soc Nephrol; 2015 Dec; 10(12):2143-51. PubMed ID: 26542163
[TBL] [Abstract][Full Text] [Related]
16. Secondary thrombotic microangiopathy and eculizumab: A reasonable therapeutic option.
Román E; Mendizábal S; Jarque I; de la Rubia J; Sempere A; Morales E; Praga M; Ávila A; Górriz JL
Nefrologia; 2017; 37(5):478-491. PubMed ID: 28946961
[TBL] [Abstract][Full Text] [Related]
17. Use of eculizumab in a systemic lupus erythemathosus patient presenting thrombotic microangiopathy and heterozygous deletion in CFHR1-CFHR3. A case report and systematic review.
de Holanda MI; Pôrto LC; Wagner T; Christiani LF; Palma LMP
Clin Rheumatol; 2017 Dec; 36(12):2859-2867. PubMed ID: 28905254
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy associated TMA in 13-year-old patient successfully treated with Eculizumab: case report.
Cody E; Claes D; Taylor V; Erkan E
BMC Nephrol; 2022 Apr; 23(1):147. PubMed ID: 35428247
[TBL] [Abstract][Full Text] [Related]
19. De novo thrombotic microangiopathy following simultaneous pancreas and kidney transplantation managed with eculizumab.
Shochet L; Kanellis J; Simpson I; Ta J; Mulley W
Nephrology (Carlton); 2017 Feb; 22 Suppl 1():23-27. PubMed ID: 28176480
[TBL] [Abstract][Full Text] [Related]
20. Secondary thrombotic microangiopathy in systemic lupus erythematosus and antiphospholipid syndrome, the role of complement and use of eculizumab: Case series and review of literature.
Kello N; Khoury LE; Marder G; Furie R; Zapantis E; Horowitz DL
Semin Arthritis Rheum; 2019 Aug; 49(1):74-83. PubMed ID: 30598332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
